Risk factors for multidrug-resistant tuberculosis in urban Pakistan: A multicenter case–control study
Authors:
Open Access
- 1 September 2012
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Mycobacteriology
- Vol. 1 (3) , 137-142
Abstract
Objective: To evaluate risk factors for multidrug-resistant tuberculosis (MDR-TB) in an urban setting of Pakistan. Design and methods: In this multicenter case–control study, patients aged 15 years old or older with sputum culture and sensitivity (C/S) diagnosed with pulmonary MDR-TB were defined as cases, whereas patients aged 15 years old or older with sputum C/S diagnosed and susceptible to pulmonary TB were regarded as controls. Fifty cases and 75 controls were enrolled from three tertiary-care hospitals in Karachi. Results: Multivariable logistic regression models showed that cases were more likely to have had a TB patient in the house prior to the diagnosis of MDR-TB (adjusted odds ratio [OR adj ]=3.1, 95% confidence interval [CI]: 1.2, 8.3) or had a history of prior TB treatment (OR adj = 4.2, 95% CI: 1.1, 15.4). Furthermore, cases compared with controls tended to be male (OR adj = 3.6, 95% CI: 1.4, 9.7), 15–25 years of age (OR adj = 3.7, 95% CI: 1.2, 11.3), of Sindhi ethnicity (adjusted OR=9.1, 95% CI: 1.9, 43.4) or with low educational attainment (OR adj OR=5.5, 95% CI: 1.7–17.6, for no formal schooling; OR adj = 3.8, 95% CI: 1.1–14.1, 1 for 1–5 school years). Conclusions: A TB patient in the house or a history of prior TB treatment was strongly associated with MDR-TB in this study. Furthermore, younger age, male gender, Sindhi ethnicity and poor educational attainment entailed a high risk for MDR-TB. Targeted educational intervention for patients and their contacts may minimize the noncompliance with prescribed TB treatment and lessen MDR-TB magnitude in settings like Karachi.Keywords
Funding Information
- University Research Council, Aga Khan University (01-II/22/MSc)
This publication has 16 references indexed in Scilit:
- Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, SpainEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Worldwide Incidence of Multidrug‐Resistant TuberculosisThe Journal of Infectious Diseases, 2002
- Drug - resistant tuberculosis in a tertiary referral teaching hospital of KoreaThe Korean Journal of Internal Medicine, 2001
- The threat of multidrug resistance: is tuberculosis ever untreatable or uncontrollable?The Lancet, 1999
- The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USAThe Lancet, 1996
- Nosocomial Transmission of Multidrug-Resistant Mycobacterium tuberculosis in SpainEmerging Infectious Diseases, 1996
- Treatment of Multidrug-Resistant TuberculosisNew England Journal of Medicine, 1993
- An Outbreak of Multidrug-Resistant Tuberculosis among Hospitalized Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1992
- Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patientsThe Lancet, 1991
- COMBINED DRUG TREATMENT OF TUBERCULOSIS. I. PREVENTION OF EMERGENCE OF MUTANT POPULATIONS OF TUBERCLE BACILLI RESISTANT TO BOTH STREPTOMYCIN AND ISONIAZID IN VITROJournal of Clinical Investigation, 1959